Z-Ligustilide Combined with Cisplatin Reduces PLPP1-Mediated Phospholipid Synthesis to Impair Cisplatin Resistance in Lung Cancer
Pengyu Geng(Dalian Institute of Chemical Physics), Guowang Xu(Dalian Institute of Chemical Physics)
Cited by 7
Related Papers
HIF-1α-HPRT1 axis promotes tumorigenesis and gefitinib resistance by enhancing purine metabolism in EGFR-mutant lung adenocarcinoma
|Journal of Experimental & Clinical Cancer Research|2024|26
Identification of <i>SPOP</i> related metabolic pathways in prostate cancer
|Oncotarget|2017|14
Identification and Validation of TRIM25 as a Glucose Metabolism Regulator in Prostate Cancer
|International Journal of Molecular Sciences|2022|8